tekst z obrazka
The Health Ministry on 19 August published for consultation a draft update of the reimbursement lists, due to take effect on 1 September. Under the proposal, 23 new products (EAN codes) are to be added to the pharmacy . more
Dr. Max, which was is owned by Penta Investments, was the largest independent pharmacy chain in Poland (not owned by a wholesaler) even before the acquisition of Mediq, and the acquisition of the latter would make it . more
Roche (along with Genentech, a Roche subsidiary) has protection from competition for Mabthera and Rituxan (rituximab a monoclonal antibody which targets CD20, used to treat B cell malignancies and B cell-mediated . more
Pharma market set to rebound in 2013
Oncological pharmaceuticals and immunosuppressive drugs were the driving force pushing the growth of the pharmaceutical market in 2008-2009. The . more
Rynek farmaceutyczny w Polsce odbije siк w 2013 r.
W latach 2008-2009 r. leki onkologiczne i immunomoduluj±ce byіy motorem wzrostu rynku lekуw. Gіуwn± tego przyczyn± byіa zmiana statusu . more
Reimbursement Act had a strong impact on the pharmaceutical distribution segment in Poland
The years 2013-2014 will be affected by the implications of the Reimbursement Act too, though the impact will be less severe than . more
PMR is a market research and consulting company active within over 25 countries of Central and Eastern Europe. Since 1995 we have been working for more than 500 global corporations, as well as for many regional companies.
Each year we run around 200 custom projects for our clients assisting them to continuously increase their market share, successfully enter new territories and optimise costs.
PMR consultants, analysts and researchers create premium value for companies that need: